How investment funds’ “greenwashing” hurts the planet
A new paper suggests that funds claiming to target climate change may do more harm than good


Want to do your bit for the environment? Don’t invest in a climate change fund. That’s according to a new paper – Doing Good or Feeling Good? Detecting Greenwashing in Climate Investing – by researchers Noel Amenc, Felix Goltz and Victor Liu at French business school Edhec. As Steve Johnson notes in the Financial Times, not only do such funds not help, they may even be “undermining the fight against global warming”.
The authors looked at exchange-traded funds issued in Europe which track various climate-focused indices from major index providers. They found several problems. One is that climate data accounts for a very small portion (a maximum of 12%) of the rationale for including a given stock in an index. Market capitalisation matters far more. In other words, a fund manager can run a “closet business-as-usual” fund stuffed with big companies, but market it as a “green” fund.
A second, related, issue is that a fund can earn a “green” badge by avoiding or even just “underweighting” the dirtiest sectors, such as the energy sector. However, as we’ve noted at MoneyWeek before, pushing listed oil firms to sell their oil fields doesn’t make the oil go away, it just moves it to a less transparent (and often less competent) operator. And as the authors point out, “it will be less easy to greenify the economy by doing away with electricity.” So just avoiding the energy sector won’t help the transition to a greener economy.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This implies that “engagement” – owning shares so as to pressurise company managements to shift direction – is the best option. Yet the study finds that companies whose environmental impact deteriorates over time (by emitting more carbon dioxide, for example) often see their weightings in an index rise rather than fall, implying that these “strategies are basically indifferent to the evolution of climate performance”. As a result, “the investment industry... does little to reallocate capital in a direction and in a manner that could incentivise companies to contribute to the climate transition.”
The study backs what many have already noted about such funds: there is often little clarity or agreement on the methodology or rationale involved. With the sector growing in popularity (assets in sustainable funds tripled in the three years to mid-2021, reports Morningstar), “greenwashing” (sometimes inadvertent) is rife. If you’re still keen to invest in a manner compatible with your views on the environment, then get your hands dirty and build your own portfolio, or at least be sure you know what’s in the funds you choose to buy. For the rest of us, now looks a good time to buy cheap, high-yielding fossil fuel stocks while the wider market’s attention is elsewhere.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published